AliveCor, a global leader in personal electrocardiogram (ECG) technology, and Luscii, Europe’s market leader in remote patient monitoring and virtual ward provision, have announced a groundbreaking collaboration. Together, they are set to launch the world’s first “virtual heart clinic in a box,” a revolutionary initiative that is poised to transform cardiac care for millions of patients worldwide.
This collaborative effort aims to make it easier for hospitals and general practitioners to deliver high-quality remote patient monitoring, ushering in a new era of cardiac care.
The Luscii Virtual Heart Clinic: Empowering Cardiologists and Patients
The Luscii Virtual Heart Clinic is a game-changer in the field of cardiac care. Designed to provide cardiologists with a comprehensive and user-friendly app, it enables remote monitoring of cardiac patients. Through the app, patients are prompted to take vital sign measurements, which are automatically analyzed to detect abnormalities. This not only enhances the patient experience but also allows clinical teams to dedicate more time to providing personalized care.
The Luscii Virtual Heart Clinic incorporates AliveCor’s advanced 6-lead ECG technology, alongside Omron blood pressure meters and scale, and Happitech PPG, within its medically certified telehealth platform, catering to over 100 conditions across 11 countries.
The collaboration between AliveCor and Luscii holds immense potential in revolutionizing cardiac care. By integrating AliveCor’s SDK solution into Luscii’s extensive network of renowned hospitals and general practitioners in Europe and Africa, the Virtual Heart Clinic aims to drive the transformation of cardiac care delivery. Through this partnership, cardiac care becomes more accessible and convenient for patients, while simultaneously alleviating the burden on healthcare systems.
Advancing Remote Patient Monitoring: Reducing In-Person Visits and Enhancing Care
Luscii’s new offering empowers healthcare providers to remotely monitor cardiac patients, significantly reducing the need for in-person visits or hospital admissions. Already, the Luscii app has demonstrated impressive results across Europe, such as a remarkable 81% reduction in unplanned admissions for heart failure patients in London and a 56% decrease in in-person visits for atrial fibrillation (AF) in Amsterdam. The partnership between AliveCor and Luscii further enhances these possibilities, granting heart patients greater control over their own health while staying connected with their care team.
AliveCor’s cutting-edge ECG technology perfectly complements Luscii’s widely used remote patient monitoring and virtual ward service. The integration of AliveCor’s SDK implementation into Luscii’s platform will be made available to all Luscii customers, with the first hospitals expected to offer
